In vitro studies have also demonstrated the contribution of HYAL-1 in tumour cell proliferation, motility, invasion, tumour growth, metastasis, and angiogenesis in breast, bladder, prostate, and colon cancer [40,41,42,43,44]. This evidence concerns the gene HYAL1 and colonic neoplasm.